{"DataElement":{"publicId":"6034877","version":"1","preferredName":"Eligibility HIV Positive With Undetectable HIV Viral Load Receive Highly Active Antiretroviral Therapy Indicator","preferredDefinition":"A response indicating whether or not an HIV-positive patient with undetectable HIV viral load is on a stable regimen of highly active anti-retroviral therapy (HAART).","longName":"HIV_HAART_RCV_IND","context":"ABTC","contextVersion":"1","DataElementConcept":{"publicId":"6034678","version":"1","preferredName":"Human Immunodeficiency Virus Positive Patient With Assessment Undetectable HIV Viral Load Measurement Receive Highly Active Antiretroviral Therapy Treatment Regimen","preferredDefinition":"Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME._Confirmation of something, such as a positive lab test. In medicine, a positive lab test indicates the presence of a disease, condition, or microorganism. (NCI)_A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Used to indicate the presence of something or someone._The final result of a determination of the value, significance, or extent of._The inability to be noticed, identified or discovered._The determination of the HIV viral load in a specimen._To take, accept, or get something offered._Drug therapy which targets retrovirus function by multiple mechanisms._A treatment plan that specifies the dosage, the schedule, and the duration of treatment.","longName":"3251065v1.0:6034676v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3251065","version":"1","preferredName":"Human Immunodeficiency Virus Positive Patient","preferredDefinition":"Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.:Confirmation of something, such as a positive lab test. In medicine, a positive lab test indicates the presence of a disease, condition, or microorganism. (NCI):A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","longName":"C14219:C0205159:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Immunodeficiency Virus","conceptCode":"C14219","definition":"The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Positive","conceptCode":"C0205159","definition":"Confirmation of something, such as a positive lab test. In medicine, a positive lab test indicates the presence of a disease, condition, or microorganism. (NCI)","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7061B43-41A5-5E65-E040-BB89AD431A94","latestVersionIndicator":"Yes","beginDate":"2011-07-01","endDate":null,"createdBy":"COLLINSP","dateCreated":"2011-07-01","modifiedBy":"ONEDATA","dateModified":"2011-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6034676","version":"1","preferredName":"With Undetectable HIV Viral Load Measurement Receive Highly Active Antiretroviral Therapy Treatment Regimen","preferredDefinition":"Used to indicate the presence of something or someone.:The inability to be noticed, identified or discovered.:The determination of the HIV viral load in a specimen.:To take, accept, or get something offered.:Drug therapy which targets retrovirus function by multiple mechanisms.:A treatment plan that specifies the dosage, the schedule, and the duration of treatment.","longName":"6034676v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Undetectable","conceptCode":"C111568","definition":"The inability to be noticed, identified or discovered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"HIV Viral Load Measurement","conceptCode":"C92544","definition":"The determination of the HIV viral load in a specimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Receive","conceptCode":"C25639","definition":"To take, accept, or get something offered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Highly Active Antiretroviral Therapy","conceptCode":"C16165","definition":"Drug therapy which targets retrovirus function by multiple mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Treatment Regimen","conceptCode":"C15697","definition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F255EC0-D081-48AD-E053-F662850A9FB1","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"TSESU","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ABTC: Adult Brain Tumor Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"5F255EC0-D092-48AD-E053-F662850A9FB1","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"TSESU","dateCreated":"2017-11-29","modifiedBy":"TSESU","dateModified":"2022-03-16","changeDescription":"Created for ABTC-1401 Eligibility - smt 11/29/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506036","version":"1","preferredName":"Yes No Not Applicable Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"YES_NO_NA_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"3261243","version":"1","preferredName":"Not Applicable","longName":"3261243","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-6581-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-08-10","modifiedBy":"RAGUNATHANU","dateModified":"2024-02-05","changeDescription":"12/15/15 added N/A as alternate VM-tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-759A-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75A4-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-7590-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2694966","version":"1","preferredName":"Ind-3b","preferredDefinition":"A response or indicator that can have a value of yes, no, or not applicable.","longName":"C49797","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Not Applicable Response","conceptCode":"C49797","definition":"A response or indicator that can have a value of yes, no, or not applicable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"3EBCA780-282F-4411-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-12","endDate":"2016-04-27","createdBy":"CURTIST","dateCreated":"2007-11-12","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 04-27-2016 per Tina Taylor approved by Dianne Reves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-757C-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ZHANGWE","dateModified":"2019-01-24","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 8/3/2015 Corrections made to VD in order to restore to original format: removed C49486 as rep term and replaced with C49797; restored long name and definition per Dianne Reeves/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4280691","version":"1","longName":"CRF CDEs","context":"ABTC","ClassificationSchemeItems":[{"publicId":"4280724","version":"1","longName":"Eligibility Checklist","context":"ABTC"}]}],"AlternateNames":[{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"If patient is HIV-positive, i","type":"Preferred Question Text","description":"If patient is HIV-positive, is the patient on a stable regimen of highly active anti-retroviral therapy (HAART) that does not include strong inhibitors and strong or moderate inducers of CYP3A4, has no requirement for concurrent antibiotics or antifungal agents for the prevention of opportunistic infection, CD4 count is above 250 cells/mcL and does patient have an undetectable HIV viral load on standard PCR-based test?","url":null,"context":"ABTC"},{"name":"ABTC 1701 TEXT 1","type":"Alternate Question Text","description":"If patient is HIV-positive, is the patient on a stable regimen of highly active anti-retroviral therapy not containing a strong inducer or inhibitor of CYP2C9, has no requirement for concurrent antibiotics or antifungal agents for the prevention of opportunistic infection, CD4 count is above 250 cells/mcL, and an undetectable HIV viral load on standard PCR-based test?","url":null,"context":"ABTC"},{"name":"ABTC 1801 Text 1","type":"Alternate Question Text","description":"If the patient is HIV infected, is the patient on effective anti-retroviral therapy with undetectable viral load within 6 months of treatment start?","url":null,"context":"ABTC"},{"name":"ABTC 1804 Text 1","type":"Alternate Question Text","description":"If the patient has HIV, are they on effective anti-retroviral therapy with undetectable viral load within 6 months of study start?","url":null,"context":"ABTC"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Is patient on effective anti-retroviral therapy with undetectable viral load within 6 months from enrollment?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Does patient known to be HIV positive meet 3.2.15 protocol criteria?","url":null,"context":"NRG"},{"name":"NGR_CRF_Text2","type":"Alternate Question Text","description":"If patient is HIV-positive, is the patient on effective anti-retroviral  therapy with undetectable viral load within 6 months of study entry and on a stable regimen of highly active anti-retroviral therapy (HAART) that does not require for concurrent antibiotics or antifungal agents for the prevention of opportunistic infection.","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_2","type":"Alternate Question Text","description":"Is patient on effective anti-retroviral therapy with an undetectable viral load within 6 months prior to step 2 registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_3","type":"Alternate Question Text","description":"Is the patient on effective anti-retroviral therapy with undetectable viral load within 6 months of registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_4","type":"Alternate Question Text","description":"Is patient on effective anti-retroviral therapy with undetectable viral load within 6 months of registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_5","type":"Alternate Question Text","description":"Is patient on effective anti-retroviral therapy with undetectable viral load within 6 months?","url":null,"context":"NRG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Is patient on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization?","url":null,"context":"NRG"},{"name":"ECOG-ACRIN - 1","type":"Alternate Question Text","description":"If the patient is Human Immunodeficiency Virus (HIV)-infected, is the patient on effective antiretroviral therapy with an undetectable viral load within 6 months?","url":null,"context":"ECOG-ACRIN"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"Is the patient on effective anti-retroviral therapy with undetectable viral load within 6 months?","url":null,"context":"NRG"}],"origin":"ABTC: Adult Brain Tumor Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F2863FC-20CA-28E9-E053-F662850A9E1B","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"TSESU","dateCreated":"2017-11-29","modifiedBy":"TSESU","dateModified":"2023-06-06","changeDescription":"Created for ABTC-1401 - smt 11/29/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}